<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03391635</url>
  </required_header>
  <id_info>
    <org_study_id>GAMHospital20171222</org_study_id>
    <nct_id>NCT03391635</nct_id>
  </id_info>
  <brief_title>Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation</brief_title>
  <official_title>Efficacy of Electroacupuncture Compared With Transcutaneous Electric Nerve Stimulation for Functional Constipation:a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this trial is to compare the efficacy of electroacupuncture versus
      transcutaneous electric nerve stimulation for functional constipation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both electroacupuncture(EA) therapy and transcutaneous electric nerve stimulation(TENS) are
      safe and effective for functional constipation, but no head to head comparing trial was
      conducted.

      Methods：102 participants with functional constipation will be recruited and randomly
      allocated into the EA group and the TENS group.Participants in both groups will receive EA or
      TENS treatment at Tianshu(ST 25), Fujie(SP 14) and Shangju xu(ST 37) 3 times a week for 8
      weeks.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.</measure>
    <time_frame>Baseline，week 8</time_frame>
    <description>The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at week 8.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The proportion of participants with an average increasing of one or more complete spontaneous bowel movements</measure>
    <time_frame>Baseline，week 4，week 20 and week 32</time_frame>
    <description>The proportion of participants with an average increasing of one or more complete spontaneous bowel movements from baseline at weeks 4 , 20 and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change number in CSBMS</measure>
    <time_frame>Baseline，week 4，week 8, week 20 and week 32</time_frame>
    <description>The change in the number of CSBMs at weeks 4 , 8 , 20 and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change number in SBMS</measure>
    <time_frame>Baseline，week 4，week 8, week 20 and week 32</time_frame>
    <description>The change in the number of SBMs at weeks 4 , 8 , 20 and 32.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion of participants with type3 or type 4 stool character</measure>
    <time_frame>Baseline，week 4，week 8, week 20 and week 32</time_frame>
    <description>According to the BRISTOL stool form scale, the proportion of participants with type3 or type 4 at weeks 4 , 8 , 20 and 32</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change number of average score in defecation difficulty</measure>
    <time_frame>Baseline，week 4，week 8, week 20 and week 32</time_frame>
    <description>The change in average score of difficulty in defecation at weeks 4 , 8 , 20 and 32</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change number of PAC-QOL score</measure>
    <time_frame>Baseline，week 8</time_frame>
    <description>The change in total score on the patients assessment of constipation quality of life questionnaire(PAC-QOL) total score at the end of week 8, compared with baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The proportion and average amount of using cathartics</measure>
    <time_frame>weeks -1 , 4 , 8 , 20 and 32.</time_frame>
    <description>The proportion and average amount of using cathartics at weeks -1 , 4 , 8 , 20 and 32.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">102</enrollment>
  <condition>Functional Constipation</condition>
  <arm_group>
    <arm_group_label>Electroacupuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment consists of 3 times a week for 8 weeks.Huatuo Brand needles (0.30×50mm or 0.30×70mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37.After acupuncture，the needle handle will be connected with the electrode in the electroacupuncture instrument.
The parameters of the electric acupuncture apparatus：Dilatational wave，the frequency is 2/10Hz，the electric current intensity is 0.1mA-1.0mA.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TranscutaneousElectricNerveStimulation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The treatment consists of 3 times a week for 8 weeks.Huatuo Brand electrode patch (50mm×50mm) and the SDZ-V EA apparatus (Suzhou Medical Appliance) will be used for ST25, SP14 and ST37.
The parameters of the electric acupuncture apparatus：Dilatational wave，the frequency is 2/10Hz，the electric current intensity is 2mA-5mA.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electroacupuncture</intervention_name>
    <description>Participants will receive electroacupuncture at bilateral ST25, SP14 and ST37 for 30 minutes each time，3 times a week for 8 weeks.</description>
    <arm_group_label>Electroacupuncture</arm_group_label>
    <other_name>EA</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TranscutaneousElectricNerveStimulation</intervention_name>
    <description>Participants will receive transcutaneous electric nerve stimulation at bilateral ST25, SP14 and ST37 for 30 minutes each time，3 times a week for 8 weeks.</description>
    <arm_group_label>TranscutaneousElectricNerveStimulation</arm_group_label>
    <other_name>TENS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Conforming to the criteria for the diagnosis of functional constipation in Rome III
             standard;

          2. Aged of 18 to 75 years;

          3. No medication for constipation has been used for at least 2 weeks before treatment.
             Except for emergency treatment, it has not received acupuncture treatment for
             constipation in the past 3 months, and has not participated in other ongoing clinical
             research.

        Exclusion Criteria:

          1. Constipation caused by irritable bowel syndrome and organically or medicated;
             secondary to endocrine, metabolic, neurogenic, or surgical constipation;

          2. Subjects with serious heart, liver, kidney damage or cognitive impairment, aphasia,
             mental disorders, or the inability to cooperate with the examination and treatment.

          3. Pregnant or lactation patients;

          4. Subjects with abdominal aortic aneurysm, abnormal enlargement of liver and spleen and
             so on.

          5. Subjects with coagulation dysfunction or anticoagulants such as warfarin and heparin
             have been used all the time.

          6. Subjects installed with the cardiac pacemaker.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuxiao Zeng</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuxiao Zeng</last_name>
    <phone>+86-15901278206</phone>
    <email>zengyuxiaozyx@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuxiao Zeng</last_name>
      <phone>+86-15901278206</phone>
      <email>zengyuxiaozyx@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Mugie SM, Benninga MA, Di Lorenzo C. Epidemiology of constipation in children and adults: a systematic review. Best Pract Res Clin Gastroenterol. 2011 Feb;25(1):3-18. doi: 10.1016/j.bpg.2010.12.010. Review.</citation>
    <PMID>21382575</PMID>
  </results_reference>
  <results_reference>
    <citation>Tran LC, Di Palma JA. Lack of lasting effectiveness of PEG 3350 laxative treatment of constipation. J Clin Gastroenterol. 2005 Aug;39(7):600-2.</citation>
    <PMID>16000928</PMID>
  </results_reference>
  <results_reference>
    <citation>Gordon M, Naidoo K, Akobeng AK, Thomas AG. Osmotic and stimulant laxatives for the management of childhood constipation. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD009118. doi: 10.1002/14651858.CD009118.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;8:CD009118.</citation>
    <PMID>22786523</PMID>
  </results_reference>
  <results_reference>
    <citation>Paré P, Bridges R, Champion MC, Ganguli SC, Gray JR, Irvine EJ, Plourde V, Poitras P, Turnbull GK, Moayyedi P, Flook N, Collins SM. Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol. 2007 Apr;21 Suppl B:3B-22B. Review.</citation>
    <PMID>17464377</PMID>
  </results_reference>
  <results_reference>
    <citation>Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011 Feb;60(2):209-18. doi: 10.1136/gut.2010.227132. Review.</citation>
    <PMID>21205879</PMID>
  </results_reference>
  <results_reference>
    <citation>Wong SW, Lubowski DZ. Slow-transit constipation: evaluation and treatment. ANZ J Surg. 2007 May;77(5):320-8. Review.</citation>
    <PMID>17497967</PMID>
  </results_reference>
  <results_reference>
    <citation>Pfeifer J. Surgical options to treat constipation: A brief overview. Rozhl Chir. 2015 Sep;94(9):349-61. Review.</citation>
    <PMID>26537099</PMID>
  </results_reference>
  <results_reference>
    <citation>Remes Troche JM, Gómez Escudero O, Icaza Chávez ME, Noble Lugo A, López Colombo A, Bielsa MV, Charúa Guindic L; Asociación Mexicana de Gastroenterología. [Guidelines for diagnosis and treatment of constipation in Mexico. C) Medical and surgical treatment]. Rev Gastroenterol Mex. 2011 Apr-Jun;76(2):141-54. Review. Spanish.</citation>
    <PMID>21724490</PMID>
  </results_reference>
  <results_reference>
    <citation>Du WF, Yu L, Yan XK, Wang FC. [Met-analysis on randomized controlled clinical trials of acupuncture and moxibustion on constipation]. Zhongguo Zhen Jiu. 2012 Jan;32(1):92-6. Review. Chinese.</citation>
    <PMID>22295840</PMID>
  </results_reference>
  <results_reference>
    <citation>Liu Z, Yan S, Wu J, He L, Li N, Dong G, Fang J, Fu W, Fu L, Sun J, Wang L, Wang S, Yang J, Zhang H, Zhang J, Zhao J, Zhou W, Zhou Z, Ai Y, Zhou K, Liu J, Xu H, Cai Y, Liu B. Acupuncture for Chronic Severe Functional Constipation: A Randomized Trial. Ann Intern Med. 2016 Dec 6;165(11):761-769. doi: 10.7326/M15-3118. Epub 2016 Sep 13.</citation>
    <PMID>27618593</PMID>
  </results_reference>
  <results_reference>
    <citation>Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Review.</citation>
    <PMID>16678553</PMID>
  </results_reference>
  <results_reference>
    <citation>Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997 Sep;32(9):920-4.</citation>
    <PMID>9299672</PMID>
  </results_reference>
  <results_reference>
    <citation>Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005 May;40(5):540-51.</citation>
    <PMID>16036506</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang X, Liu Y, Liu B, He L, Liu Z, Yan Y, Liu J, Liu B. Factors related to acupuncture response in patients with chronic severe functional constipation: Secondary analysis of a randomized controlled trial. PLoS One. 2017 Nov 22;12(11):e0187723. doi: 10.1371/journal.pone.0187723. eCollection 2017.</citation>
    <PMID>29166673</PMID>
  </results_reference>
  <results_reference>
    <citation>Ismail KA, Chase J, Gibb S, Clarke M, Catto-Smith AG, Robertson VJ, Hutson JM, Southwell BR. Daily transabdominal electrical stimulation at home increased defecation in children with slow-transit constipation: a pilot study. J Pediatr Surg. 2009 Dec;44(12):2388-92. doi: 10.1016/j.jpedsurg.2009.07.063.</citation>
    <PMID>20006033</PMID>
  </results_reference>
  <results_reference>
    <citation>Clarke MC, Chase JW, Gibb S, Hutson JM, Southwell BR. Improvement of quality of life in children with slow transit constipation after treatment with transcutaneous electrical stimulation. J Pediatr Surg. 2009 Jun;44(6):1268-72; discussion 1272. doi: 10.1016/j.jpedsurg.2009.02.031.</citation>
    <PMID>19524752</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 22, 2017</study_first_submitted>
  <study_first_submitted_qc>January 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2018</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guang'anmen Hospital of China Academy of Chinese Medical Sciences</investigator_affiliation>
    <investigator_full_name>Yuxiao Zeng</investigator_full_name>
    <investigator_title>Postgraduate student of China Academy of Chinese Medical Sciences</investigator_title>
  </responsible_party>
  <keyword>acupuncture</keyword>
  <keyword>functional constipation</keyword>
  <keyword>transcutaneous electric nerve stimulation</keyword>
  <keyword>randomized controlled trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

